Skip to main content

Table 4 Patients characteristics and the use of antimicrobials

From: The late phase of sepsis is characterized by an increased microbiological burden and death rate

phases in relation to diagnosis

phase 0

phase I

phase II

phase III

Overall

        

# of patients on ICU during phase, #

661

999

690

327

SOFA Score, mean ± SD

8.5 ± 3.6

9.6 ± 3.8*

8.4 ± 4.0

7.1 ± 3.9

PCT, mean ± SD

5.0 ± 10.8

10.3 ± 23.5*

3.2 ± 8.5

2.0 ± 4.9

Requirement of mechanical ventilation, % (#)

78.8 (521)

90.9 (908)*

82.8 (571)

83.8 (274)

Requirement of renal replacement therapy, % (#)

13.2 (87)§

27.7 (277)

28.7 (198)

30.9 (101)

Treatment with antimycotica, % (#)

5.1 (34)2

10.6 (106)2

17.5 (121)2

28.7 (94)2

Amphotericin

2.6 (17)

3 (30)

4.8 (33)

8 (26)

Fluconazole/Itroconazole/Ketoconazole

2 (13)

5.3 (53)

9.6 (66)

20.8 (68)

Voriconazole

1.1 (7)

1.8 (18)

4.1 (28)

5.2 (17)

Echinocadine (Anidulafungin/Caspofungin)

0.3 (2)

1.3 (13)

1.9 (13)

3.4 (11)

Treatment with antibiotica, % (#)

75.2 (497)2

97.5 (974)2

91.6 (632)2

81.3 (266)2

Glycopeptides (Teichoplanin/Vancomycine)

10.3 (68)

19.2 (192)

31.3 (216)

34.3 (112)

aminoglycosides

5.3 (35)

7.9 (79)

7.5 (52)

10.7 (35)

Glycylcyclines

1.2 (8)

1.8 (18)

4.6 (32)

11.3 (37)

quinolones

11.8 (78)

18.1 (181)

24.8 (171)

38.2 (125)

carbapenems

15.8 (104)

35.2 (352)

48.1 (332)

40.1 (131)

cephalosporins (3rd/4th generation)

11.8 (78)

14.4 (144)

14.3 (99)

20.2 (66)

tetracyclines

0 (0)

0.2 (2)

0.1 (1)

0.3 (1)

ansamycins

2 (13)

2.7 (27)

2.8 (19)

3.4 (11)

oxazolidinones

1.4 (9)

2.4 (24)

3.5 (24)

8 (26)

penicillin

39.2 (259)

57.1 (570)

39.9 (275)

27.5 (90)

others+

31.3 (207)

29.5 (295)

28.4 (196)

27.2 (89)

In dependency of bloodculture results

bc -

bc +

bc -

bc +

bc -

bc +

bc -

bc +

SOFA Score, mean ± SD

9.19 ± 3.93

9.29 ± 4.02

10.02 ± 3.58

10.52 ± 3.67

9.58 ± 3.7

10.18 ± 4.53

8.7 ± 3.51

8.42 ± 4.07

PCT, mean ± SD

5.24 ± 7.38

8.1 ± 11.34

12.12 ± 25.25

20.86 ± 43.82³

3.09 ± 7.82

6.68 ± 12.32³

2.07 ± 4.12

4.89 ± 12.5³

Requirement of mechanical ventilation, % (#)

76.4 (120/157)

100 (7/7)

79.3 (521/657)

95.4 (103/108)³

66 (210/318)

92.5 (37/40)³

44.8 (126/281)

79.2 (38/48)³

Requirement of renal replacement therapy, % (#)

85.7 (36/42)

100 (2/2)

84.9 (141/166)

100 (30/30)³

81.8 (54/66)

90.9 (10/11)

48.2 (39/81)

85.7 (18/21)³

  1. Selected characteristics and antimicrobial treatment of patients corresponding to the distinct phases are demonstrated. The absolute, relative numbers and mean ± SDs are given. CNS, coagulase negative staphylococci; +, others include cephalosporins of the first and second generation, lincosamides, folic acid antagonists, macrolide antibiotics and nitroimidazole; #, absolute numbers; %, relative number; bc, blood cultures; *, indicates statistically significant difference compared to phase 0, phase II and phase III (P ≤ 0.05; ANOVA and χ2 test); §, indicates statistically significant difference compared to phase I, phase II and phase III (P ≤ 0.01; ANOVA); 2, indicates statistically significant differences between all phases (P ≤ 0.05; ANOVA); ³, indicates statistically significant difference compared to bc- (P ≤ 0.05; ANOVA and χ2 test).